Your hard-earned money would be better spent elsewhere.

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Sarepta Therapeutics (SRPT) and Prothena (PRTA). But which of these two stocks is more attractive to value ...

Looking ahead to 2030, our model projects SRPT could trade at an average price of $19.44, with a potential range between $14.58 and $24.30. This represents a potential 2.6% return from today's price.

In a report released today, Eliana Merle from Barclays maintained a Hold rating on Sarepta Therapeutics, with a price target of $20.00. Unlock powerful investing tools and data-driven insights with ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

・The FDA accepted the filings for review and set a target decision date of February 28, 2027. ・The applications rely on results from a confirmatory study plus years of real-world data from patients ...